Tanya Lewis to join Vion Pharmaceuticals
This article was originally published in Scrip
Tanya Lewis is to join Vion Pharmaceuticals (US) as vice-president of regulatory and quality affairs. Ms Lewis has been advising Vion on regulatory matters and working on the NDA filing for laromustine (Cloretazine, VNP40101M) since August as a consultant. Before that, she was at Millennium Pharmaceuticals for more than seven years where she was most recently a senior director in the regulatory affairs department.